{"id":12167,"date":"2018-12-17T14:12:36","date_gmt":"2018-12-17T14:12:36","guid":{"rendered":"https:\/\/www.wma.net\/wp-content\/uploads\/2018\/12\/Invitation_EB144-NSA-English.pdf"},"modified":"2018-12-17T14:12:36","modified_gmt":"2018-12-17T14:12:36","slug":"invitation_eb144-nsa-english-2","status":"inherit","type":"attachment","link":"https:\/\/www.wma.net\/es\/seccion-de-miembros\/servicios-y-eventos\/invitations-to-external-meetings\/invitation_eb144-nsa-english-2\/","title":{"rendered":"Invitation_EB144 NSA English"},"author":10,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.wma.net\/wp-content\/uploads\/2018\/12\/Invitation_EB144-NSA-English.pdf'>Invitation_EB144 NSA English<\/a><\/p>\n<p>20, AVENUE APPIA \u2013 CH-1211 GENEVA 27 \u2013 SWITZERLAND \u2013 TEL CENTRAL +41 22 791 2111 \u2013 FAX CENTRAL +41 22 791 3111 \u2013 WWW.WHO.INT<br \/>\n&#8230; ENCLS: (3) EB\/19.4<br \/>\nThe Director-General of the World Health Organization (WHO) has the honour to invite<br \/>\nthe non-State actors in official relations with WHO, in accordance with privileges conferred on<br \/>\nthem, to appoint representatives to attend the 144th session of the Executive Board which will be<br \/>\nconvened on Thursday, 24 January 2019, at 09:30, at the Organization\u2019s headquarters, Geneva,<br \/>\nSwitzerland. The session will close no later than Friday, 1 February 2019.<br \/>\nRegistration can be initiated as of 18 December 2018 by going to the following link:<br \/>\nhttp:\/\/extranet.who.int\/bpmext\/meetingregistration.aspx, using the following username: ebuser,<br \/>\nand password: Hamiki28. Instructions for online registration are available for downloading from<br \/>\nthe Governance website (http:\/\/apps.who.int\/gb\/gov\/registration.html).<br \/>\n&#8230; A copy of the provisional agenda, provisional annotated agenda for this session and a copy<br \/>\nof \u201cPractical information for delegates of non-State actors in official relations with the World<br \/>\nHealth Organization\u201d are also enclosed.<br \/>\nAs agreed by the Executive Board at its 143rd session, governing body meetings are now<br \/>\npaperless.<br \/>\nThe documents for the 144th session of the Executive Board can be accessed on the<br \/>\nInternet through the WHO website (http:\/\/www.who.int\/gb\/), as they become available.<br \/>\nGENEVA, 27 November 2018<br \/>\nGBS\/NSA\/EB144\/19.4<br \/>\n1 e e ec e r 2 r 1 ebr r 201<br \/>\ne r er e e<br \/>\nr c c rm r e e e e c r<br \/>\nc re e r e r<br \/>\n1. The 144th session of the WHO Executive Board will meet at WHO headquarters, Geneva, from<br \/>\nThursday, 24 January to Friday, 1 February 2019, commencing at 09:30. The information below is<br \/>\nintended to facilitate the participation of non-State actors in official relations with the World Health<br \/>\nOrganization (WHO) at the Executive Board.<br \/>\ne r c ec c b e<br \/>\ne r<br \/>\n2. Online registration is required for the Executive Board. To that end, the invitation letter to the<br \/>\nExecutive Board provides a link to the WHO Governing Bodies eeting Registration System, as well<br \/>\nas a username and password that will give access to the system. Each non-State actor must designate a<br \/>\nfocal point to be responsible for registering its delegation in the system, and giving its delegates copies<br \/>\nof the invitation and enclosures as well as the non-State actors\u2019 letter of credentials.<br \/>\n3. Online registration requires each non-State actor to upload a copy of its credentials, that is, a<br \/>\nsigned response to the invitation on the non-State actor\u2019s letterhead indicating the name of the head of<br \/>\ndelegation, the name(s) of the other representatives, function of each delegate in the non-State actor<br \/>\nitself and, where appropriate, in an affiliated non-State actor. In accordance with the submitted delegate<br \/>\ninformation, official EB badges will be prepared in advance. The deadline for registration is<br \/>\n10 January 2019.<br \/>\n4. Instructions for the online registration system are available on the Governance website at<br \/>\nhttp:\/\/www.who.int\/governance\/registration\/en\/index.html. ueries concerning the system can be<br \/>\naddressed by email to supportregistration who.int, or by telephone 41 22 791 2111.<br \/>\n. As of January 201 , for security reasons, all delegates are required to wear photo ID badges in<br \/>\norder to access the meeting room. For this reason, during the online registration process, the Focal Point<br \/>\nwill be asked to upload a passport style photograph of each member of the delegation.<br \/>\n. Guidance on the nature of the image required, and brief instructions on how to upload and<br \/>\nresize an existing image you may have, are both available on the WHO website:<br \/>\nhttp:\/\/www.who.int\/governance\/en\/.<br \/>\n7. An example of credentials is attached for ease of reference.<br \/>\n8. Registered representatives of non-State actors appear in the official WHO records as participants.<br \/>\nindly note that during registration the affiliation of each delegate is required. While the non-State<br \/>\nactors are invited to appoint a representative or representatives to attend the Executive Board,<br \/>\ndisproportionate representation at the meetings is to be avoided.<br \/>\nec b e<br \/>\n9. pon arrival at WHO headquarters, delegates should show the credentials letter and proof of<br \/>\nidentity, for example, a passport to the Reception at WHO headquarters. Representatives may obtain<br \/>\ntheir badges as from Thursday, 17 January 2019 at 11:00.<br \/>\n&#8211; 2 &#8211;<br \/>\nGBS\/NSA\/EB144\/19.4<br \/>\nre reme<br \/>\n10. Non-State actors\u2019 representatives that require a visa to enter Switzerland must obtain a Schengen<br \/>\nvisa from the Swiss embassy or consulate in, or closest to, their country of residence it cannot be<br \/>\nobtained from the embassy of another Schengen country. Delivery of a Schengen visa takes between<br \/>\n7 and 21 days, so any visa application should be lodged well in advance of the expected date of travel.<br \/>\n11. It is recommended that participants apply for a Schengen visa Type C, which entitles the holder<br \/>\nto visit or transit other Schengen states, including neighbouring France. Applicants for a Schengen visa<br \/>\nmust attach a support letter to their applications. The requests for a support letter from WHO should be<br \/>\nsent at the latest, one month before the first day of the Executive Board and addressed to<br \/>\nnonstateactors who.int, providing the following information:<br \/>\nName on passport:<br \/>\nTitle:<br \/>\nNationality:<br \/>\nDate of birth:<br \/>\nPassport no:<br \/>\nIssue date:<br \/>\nExpiry date:<br \/>\nPlease note that visa applications made in several different places will be re ected.<br \/>\nec e r c me<br \/>\n12. As they become available, documents for the Executive Board are posted on the WHO website<br \/>\nat http:\/\/www.who.int\/gb\/. They are available in Arabic, Chinese, English, French, Russian and Spanish,<br \/>\nthe official languages of WHO.<br \/>\n13. As agreed by the Executive Board at its 143rd session, governing body meetings are now<br \/>\npaperless.<br \/>\ne rr eme<br \/>\n14. Seating for non-State actors is reserved in the gallery located above to the left side of the EB<br \/>\nroom.<br \/>\ne c r eme e r<br \/>\n1 . A non-State actor in official relations with WHO may request to speak under a technical item in<br \/>\nwhich the non-State actor has a particular interest. The following process applies to such requests:<br \/>\nNon-State actors wishing to make a statement should notify the Partnerships and non-State<br \/>\nactors\u2019 Department (PNA) nsastatements who.int at the latest by 08:00 am of the day when<br \/>\nthe agenda item is scheduled to be discussed.<br \/>\nWhen submitting a request, the non-State actor should provide the name of the entity, the name<br \/>\nof the representative that will deliver the statement and the technical agenda item under which<br \/>\nthe statement will be made.<br \/>\nWhile every attempt is made to keep non-State actors informed of the status of their requests,<br \/>\nit is the responsibility of the non-State actor to verify with PNA that the request has been<br \/>\nreceived. PNA will inform the Chairperson of the meeting of the names of the non-State actors<br \/>\nwishing to make a statement.<br \/>\n&#8211; 3 &#8211;<br \/>\nGBS\/NSA\/EB144\/19.4<br \/>\nTo note, the statements will be made only at the invitation of the Chairperson.<br \/>\nStatements should be directly relevant to both the agenda item and to the document prepared<br \/>\nfor the item. Accuracy of the technical components should be considered. The titles of<br \/>\nindividuals, organizations and\/or specific doctrines are expected to be correct and there should<br \/>\nbe no spelling\/grammatical errors.<br \/>\nStatements should not raise issues of purely political nature that are unrelated to the topic, and<br \/>\nshould not contain any inappropriate or offensive reference to ember States. The<br \/>\nnomenclature used to refer to ember States, or areas of ember States, must follow that of<br \/>\nthe nited Nations. In case of doubt, please consult nsastatements who.int.<br \/>\nStatements should be limited to about 300 words (19 0 characters) which should not take longer<br \/>\nthan two minutes to deliver.<br \/>\nNon-State actors have the possibility to submit their statements in advance of the debate for the<br \/>\nSecretariat to post on a dedicated website. This will enable non-State actors to make their inputs<br \/>\nand contributions known prior to the debates. For that purpose, the entities are invited to register<br \/>\nat https:\/\/extranet.who.int\/nonstateactorsstatements\/. Once the registration form has been<br \/>\nsubmitted, an approval email will be sent with relevant details on the process to be followed.<br \/>\nStatements posted may include a footnote with a link to the non-State actors\u2019 website for further<br \/>\ninformation. To note, the statements are posted for a limited time, and will not be retained on<br \/>\nthe website thereafter.<br \/>\nThe summary records of the Executive Board, which will be published after the meetings, will<br \/>\nreflect only those statements delivered during the working sessions.<br \/>\nStatements longer than 300 words, those that were posted but were not delivered during the<br \/>\nworking sessions or those that do not follow the process described in this note will not be<br \/>\nallowed to be posted on the website or can be withdrawn at the WHO\u2019s Secretariat\u2019s sole<br \/>\ndiscretion.<br \/>\nIf the non-State actor decides not to post the statement on the dedicated website, its<br \/>\nrepresentative is invited to send a copy to nsastatements who.int prior to its delivery.<br \/>\ne be re e r<br \/>\n1 . Statements are delivered from the \u201cSpeakers\u201d seat in the EB room. Please consult the seating<br \/>\nplan, placed on the wall at the entrance of the Executive Board room.<br \/>\n17. It is important that speakers follow the debate on the item which they wish to address. Shortly<br \/>\nbefore the ember States have finished speaking on the item, non-State actor speakers should leave the<br \/>\ngallery and move to the allocated \u201cSpeakers\u201d seat in the EB room. If the \u201cSpeakers\u201d seat is occupied,<br \/>\nthe huissier will help to find alternative seating. The Chairperson will invite the speaker to take the floor.<br \/>\nAfter the statement, the speaker is invited to move from the seat promptly to enable the following<br \/>\nspeaker to take his\/her place. It is the responsibility of the speakers to ensure their presence for the item<br \/>\nin the EB room.<br \/>\n18. Should it not be possible for the speaker to be present, he or she may arrange for another<br \/>\nrepresentative to deliver the statement. Notification of the name of the new speaker should be sent to<br \/>\nnsastatements who.int. The person nominated should be on the list of delegates of the respective<br \/>\nnon-State actor as the original speaker, and should have registered and collected his\/her badge. In cases<br \/>\nwhere a non-State actor has not been able to nominate another person to make the statement, it is not<br \/>\npossible for the statement to be presented to the Executive Board or appear in written form in the official<br \/>\nrecords of the Executive Board proceedings.<br \/>\n&#8211; 4 &#8211;<br \/>\nGBS\/NSA\/EB144\/19.4<br \/>\nDe r me r r er e c r<br \/>\n19. PNA serves as the focal point for assisting non-State actors during the Executive Board. For<br \/>\nenquiries please contact PNA at nonstateactors who.int.<br \/>\n20. ueries concerning the online registration system can be addressed by email to<br \/>\nsupportregistration who.int, or by telephone 41 22 791 2111.<br \/>\n\u00a0<br \/>\nGBS\/NSA\/EB144\/19.4\u00a0<br \/>\nNon\u2010State\u00a0actor\u00a0letterhead\u00a0<br \/>\n\u00a0<br \/>\n\u00a0<br \/>\nWorld\u00a0Health\u00a0Organization\u00a0<br \/>\nThe\u00a0Director\u00a0<br \/>\nDepartment\u00a0of\u00a0Governing\u00a0Bodies\u00a0<br \/>\n20\u00a0Avenue\u00a0Appia\u00a0<br \/>\n1211\u00a0Geneva\u00a027\u00a0<br \/>\n\u00a0<br \/>\n\u00a0<br \/>\nDate\u00a0<br \/>\n\u00a0<br \/>\nDear\u00a0Dr\u00a0Armstrong,\u00a0<br \/>\n\u00a0<br \/>\nPlease\u00a0find\u00a0below\u00a0the\u00a0names\u00a0of\u00a0our\u00a0representatives\u00a0who\u00a0will\u00a0attend\u00a0the\u00a0144th\u00a0session\u00a0of\u00a0the\u00a0<br \/>\nExecutive\u00a0Board,\u00a0which\u00a0will\u00a0be\u00a0held\u00a0from\u00a024\u00a0January\u00a0to\u00a01\u00a0February\u00a02019\u00a0in\u00a0Geneva,\u00a0Switzerland.\u00a0<br \/>\n\u00a0<br \/>\nMs\u00a0X.\u00a0Smith\u00a0<br \/>\nBusiness\u00a0title\u00a0<br \/>\nAffiliation\u00a0(name\u00a0of\u00a0the\u00a0non\u2010State\u00a0actor\u00a0in\u00a0official\u00a0relations\u00a0or\u00a0its\u00a0member\u00a0organization,\u00a0a\u00a0branch,\u00a0<br \/>\nsubsidiary\u00a0or\u00a0division,\u00a0whichever\u00a0applies\u00a0to\u00a0the\u00a0delegate)\u00a0<br \/>\n\u00a0<br \/>\nDr\u00a0D.\u00a0Thompson\u00a0<br \/>\nBusiness\u00a0title\u00a0<br \/>\nAffiliation\u00a0(name\u00a0of\u00a0the\u00a0non\u2010State\u00a0actor\u00a0in\u00a0official\u00a0relations\u00a0or\u00a0its\u00a0member\u00a0organization,\u00a0a\u00a0branch,\u00a0<br \/>\nsubsidiary\u00a0or\u00a0division,\u00a0whichever\u00a0applies\u00a0to\u00a0the\u00a0delegate)\u00a0<br \/>\n\u00a0<br \/>\nWith\u00a0best\u00a0regards,\u00a0<br \/>\n\u00a0<br \/>\nName,\u00a0signature\u00a0and\u00a0title\u00a0of\u00a0a\u00a0senior\u00a0official\u00a0<br \/>\n\u00a0<br \/>\n\u00a0<br \/>\nEXECUTIVE BOARD EB144\/1<br \/>\n144th session 19 November 2018<br \/>\nGeneva, 24 January\u20131 February 2019<br \/>\nr e<br \/>\n1 e e e e e<br \/>\nDocuments EB144\/1 and EB144\/1 (annotated)<br \/>\n2 e r b e D rec r e er<br \/>\nDocument EB144\/2<br \/>\ne r e e mm ee<br \/>\nDocument EB144\/3<br \/>\ne r e r r mme e m r mm ee e ec e r<br \/>\nDocument EB144\/4<br \/>\nr e c r r m er<br \/>\n.1 Proposed programme budget 2020 2021<br \/>\nDocuments EB144\/ , EB144\/ and EB144\/7<br \/>\n.2 Public health preparedness and response: Report of the Independent Oversight and<br \/>\nAdvisory Committee for the WHO Health Emergencies Programme<br \/>\nDocument EB144\/8<br \/>\n.3 Polio<br \/>\nEradication<br \/>\nDocument EB144\/9<br \/>\nTransition<br \/>\nDocument EB144\/10<br \/>\n.4 Implementation of the 2030 Agenda for Sustainable Development<br \/>\nDocument EB144\/11<br \/>\nEB144\/1<br \/>\n2<br \/>\n. niversal health coverage<br \/>\nPrimary health care towards universal health coverage<br \/>\nDocument EB144\/12<br \/>\nCommunity health workers delivering primary health care: opportunities and challenges<br \/>\nDocument EB144\/13<br \/>\nPreparation for the high-level meeting of the nited Nations General Assembly on<br \/>\nuniversal health coverage<br \/>\nDocument EB144\/14<br \/>\n. Health, environment and climate change<br \/>\nDocuments EB144\/1 and EB144\/1<br \/>\n.7 edicines, vaccines and health products<br \/>\nAccess to medicines and vaccines<br \/>\nDocument EB144\/17<br \/>\nCancer medicines<br \/>\nDocument EB144\/18<br \/>\n.8 Follow-up to the high-level meetings of the nited Nations General Assembly on<br \/>\nhealth-related issues<br \/>\nAntimicrobial resistance<br \/>\nDocument EB144\/19<br \/>\nPrevention and control of noncommunicable diseases<br \/>\nDocument EB144\/20<br \/>\nEnding tuberculosis<br \/>\nDocument EB144\/21<br \/>\n.9 Eleventh revision of the International Classification of Diseases<br \/>\nDocument EB144\/22<br \/>\nEB144\/1<br \/>\n3<br \/>\ner ec c m er<br \/>\n.1 Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and<br \/>\naccess to vaccines and other benefits<br \/>\nDocument EB144\/23<br \/>\n.2 ember State mechanism on substandard and falsified medical products<br \/>\nDocument EB144\/24<br \/>\n.3 Human resources for health<br \/>\nDocuments EB144\/2 and EB144\/2<br \/>\n.4 Promoting the health of refugees and migrants<br \/>\nDocument EB144\/27<br \/>\n. Accelerating cervical cancer elimination<br \/>\nDocument EB144\/28<br \/>\n. Patient safety<br \/>\nGlobal action on patient safety<br \/>\nDocument EB144\/29<br \/>\nWater, sanitation and hygiene in health care facilities<br \/>\nDocument EB144\/30<br \/>\ner m r e er ce m er<br \/>\n7.1 WHO reform processes, including the transformation agenda, and implementation of<br \/>\nnited Nations development system reform<br \/>\nDocuments EB144\/31, EB144\/32, EB144\/33, and EB144\/34<br \/>\n7.2 Evaluation of the election of the Director-General of the World Health Organization<br \/>\nDocument EB144\/3<br \/>\n7.3 Engagement with non-State actors<br \/>\nDocuments EB144\/3 and EB144\/37<br \/>\nEB144\/1<br \/>\n4<br \/>\n7.4 embership of the Independent Expert Oversight Advisory Committee if any<br \/>\n7. ultilingualism<br \/>\nDocument EB144\/38<br \/>\n7. World health days<br \/>\nDocument EB144\/39<br \/>\n7.7 Reports of committees of the Executive Board<br \/>\nFoundations and awards<br \/>\nDocument EB144\/40<br \/>\n7.8 Future meetings of the governing bodies<br \/>\nProvisional agenda of the Seventy-second World Health Assembly<br \/>\nDocument EB144\/41<br \/>\nDate and place of the 14 th session of the Executive Board<br \/>\nDocument EB144\/42<br \/>\n8 c m er<br \/>\n8.1 Overview of financing and implementation of the Programme budget 2018 2019<br \/>\nDocument EB144\/43<br \/>\n8.2 Scale of assessments for 2020 2021<br \/>\nDocument EB144\/44<br \/>\n8.3 Amendments to the Financial Regulations and Financial Rules if any<br \/>\nm re rce<br \/>\n9.1 Appointment of the Regional Director for South-East Asia<br \/>\nDocument EB144\/4<br \/>\n9.2 Appointment of the Regional Director for the Western Pacific<br \/>\nDocument EB144\/4<br \/>\nEB144\/1<br \/>\n5<br \/>\n9.3 Statement by the representative of the WHO staff associations<br \/>\nDocument EB144\/INF.\/1<br \/>\n9.4 Report of the Ombudsman<br \/>\nDocument EB144\/INF.\/2<br \/>\n9. Human resources update, including on the global internship programme<br \/>\nDocuments EB144\/47 and EB144\/47 Add.1<br \/>\n9. Report of the International Civil Service Commission<br \/>\nDocument EB144\/48<br \/>\n9.7 Amendments to the Staff Regulations and Staff Rules<br \/>\nDocument EB144\/49<br \/>\n10 er r rm<br \/>\n10.1 Outcome of the Second International Conference on Nutrition<br \/>\nDocument EB144\/ 0<br \/>\n10.2 Evaluation: update<br \/>\nDocument EB144\/ 1<br \/>\n10.3 Reports of advisory bodies<br \/>\nExpert committees and study groups<br \/>\nDocuments EB144\/ 2 and EB144\/ 2 Add.1<br \/>\n11 re e e<br \/>\nEXECUTIVE BOARD EB144\/1 annotate<br \/>\n144th session 19 November 2018<br \/>\nGeneva, 24 January\u20131 February 2019<br \/>\nr e e<br \/>\n1 e e e e e<br \/>\n2 e r b e D rec r e er<br \/>\ne r e e mm ee<br \/>\nIn 2012, in decision WHA (9), the Health Assembly endorsed the proposal that the chairpersons of the regional<br \/>\ncommittees routinely submit to the Board summary reports of the committees\u2019 deliberations. The Board will be<br \/>\ninvited to consider the recommendations of the regional committees.<br \/>\ne r e r r mme e m r mm ee e ec e r<br \/>\nThe Board will receive at the opening of its session the report of the twenty-ninth meeting of the Programme,<br \/>\nBudget and Administration Committee, which is scheduled to be held from 21 to 23 January 2019.<br \/>\nr e c r r m er<br \/>\n.1 Proposed programme budget 2020 2021<br \/>\nFollowing review and discussion by the regional committees, a revised draft of the Proposed programme budget<br \/>\n2020 2021 will be presented for consideration by the Board.<br \/>\nIn ay 2018, the Seventy-first World Health Assembly considered a report from the Executive Board\u2019s<br \/>\nProgramme, Budget and Administration Committee (document A71\/4 ), which discussed a financial estimate for<br \/>\nthe Thirteenth General Programme of Work, 2019 2023 (contained in document EBPBAC28\/ ). The Director-<br \/>\nGeneral will submit a report providing an update on progress in the implementation of the action points for value<br \/>\nfor money contained in the financial estimate, together with information on the next steps in WHO\u2019s value for<br \/>\nmoney strategy.<br \/>\nPursuant to resolution WHA71.1 (2018), in which the Executive Board requested the Director-General, inter<br \/>\nalia, to use the Thirteenth General Programme of Work as the basis for the strategic direction of WHO\u2019s work<br \/>\nduring the period 2019 2023, the Director-General will present the WHO Impact Framework. The Impact<br \/>\nFramework will provide the following: an overarching measure of healthy life expectancy indices for each of<br \/>\nthe triple billion targets and a set of programmatic targets.<br \/>\n.2 Public health preparedness and response: Report of the Independent Oversight and<br \/>\nAdvisory Committee for the WHO Health Emergencies Programme<br \/>\nThe Chair of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme<br \/>\nwill present the Committee\u2019s fifth report to the governing bodies. The report will provide the Committee\u2019s<br \/>\nEB144\/1 (annotated)<br \/>\n2<br \/>\nobservations and recommendations based on its review of WHO\u2019s work in ma or outbreaks and other health<br \/>\nemergencies during the period ay December 2018.<br \/>\n.3 Polio<br \/>\nEradication<br \/>\nThe report by the Director-General will provide a status update on polio eradication, summarizing programmatic,<br \/>\nepidemiological and financial challenges to securing a lasting polio-free world, and will introduce the concept of<br \/>\na new strategic plan to achieve global certification by 2023, taking into account the fact that circulation of wild<br \/>\npoliovirus has not yet been interrupted.<br \/>\nTransition<br \/>\nThe report to the Executive Board will provide a status update on the implementation of the strategic action plan<br \/>\non Polio Transition, which was noted by the Seventy-first World Health Assembly in ay 2018.<br \/>\n.4 Implementation of the 2030 Agenda for Sustainable Development<br \/>\nIn line with resolution WHA 9.11 (201 ) the Director-General will submit a report on attainment of the<br \/>\nhealth-related Sustainable Development Goals. Part I of the report will summarize global and regional progress<br \/>\nmade by ember States towards achieving Goal 3 (Ensure healthy lives and promote well-being for all at all<br \/>\nages), as well as other health-related Goals and targets. Part II will describe the progress made in implementing<br \/>\nresolution WHA 9.11.<br \/>\n. niversal health coverage<br \/>\nember States have committed themselves to achieving universal health coverage in Sustainable Development<br \/>\nGoal 3, target 3.8 and in the Thirteenth General Programme of Work, 2019 2023, in line with the requests made<br \/>\nof the WHO Secretariat and ember States in various nited Nations General Assembly resolutions, and with<br \/>\nthe commitment towards a high-level meeting of the General Assembly on universal health coverage, to be held<br \/>\nin 2019. In moving forward to implement universal health coverage, the WHO Secretariat, ember States and<br \/>\ndevelopment partners must also make progress in respect of two central areas: primary health care and the health<br \/>\nworkforce.<br \/>\nPrimary health care towards universal health coverage<br \/>\nThe Declaration of Alma-Ata in 1978 was a landmark in the history of global health. Forty years later, the<br \/>\nGlobal Conference on Primary Health Care (Astana, azakhstan, October 2018) and its associated Declaration<br \/>\nrenewed a commitment to primary health care in pursuit of health and well-being for all and will help to provide<br \/>\na foundation for the forthcoming nited Nations high-level meeting on universal health coverage. At the request<br \/>\nof a ember State, the Director-General will present a report outlining the rationale for the renewal of primary<br \/>\nhealth care to address health and health system challenges in the 21st century, key lessons learned through the<br \/>\nimplementation of primary health care over the past 40 years, and future directions for consideration by ember<br \/>\nStates as they operationalize the Declaration of Astana.<br \/>\nCommunity health workers delivering primary health care: opportunities and<br \/>\nchallenges<br \/>\nIn the Declaration of Astana ( azakhstan, October 2018) Heads of State and Government committed themselves<br \/>\nto investing in the primary health care workforce in order to accelerate progress towards universal health<br \/>\ncoverage. At the request of a ember State, the Director-General will present a report that examines effective<br \/>\nhealth workforce strategies, which include, in some contexts, the education and deployment of community health<br \/>\nEB144\/1 (annotated)<br \/>\n3<br \/>\nworkers within a primary care team. The report will also give details of a new WHO guideline that examines<br \/>\nopportunities and challenges for the successful education, remuneration, deployment and supervision of<br \/>\ncommunity health workers.<br \/>\nPreparation for the high-level meeting of the nited Nations General Assembly on<br \/>\nuniversal health coverage<br \/>\nIn 2017, the nited Nations General Assembly decided in resolution 72\/139 to hold a high-level meeting on<br \/>\nuniversal health coverage in 2019 and requested WHO to collaborate closely with the President of the General<br \/>\nAssembly, in consultation with ember States, to ensure the most effective and efficient outcomes. At the<br \/>\nrequest of ember States, the Director-General will present a report to enable the Board to consider the<br \/>\nSecretariat\u2019s preparations to date and to provide guidance on next steps.<br \/>\n. Health, environment and climate change<br \/>\nIn line with decision EB142( ) (2018) the Director-General will present two reports to the Board for its<br \/>\nconsideration. The first will contain a draft comprehensive global strategy on health, environment and climate<br \/>\nchange and will request the Board to provide any guidance necessary. The Board will be invited to note this<br \/>\nreport and provide further comments and guidance on the draft WHO global strategy on health, environment and<br \/>\nclimate change. The second will provide an update on progress made by the Secretariat in its work to prepare a<br \/>\ndraft action plan for the flagship initiative to address health effects of climate change in small island developing<br \/>\nStates. The Executive Board will be invited to consider the draft action plan and provide further guidance as<br \/>\nappropriate.<br \/>\n.7 edicines, vaccines and health products<br \/>\nAccess to medicines and vaccines<br \/>\nAs requested by ember States during the Seventy-first World Health Assembly, the Secretariat has prepared a<br \/>\ndraft road map report outlining the programming of WHO\u2019s work on access to medicines, vaccines and health<br \/>\nproducts. Lack of access to safe, effective, quality and affordable medicines and vaccines continues to impede<br \/>\nprogress towards universal health coverage. The draft road map will elaborate activities, actions and deliverables<br \/>\nfor the period 2019 2023 to address the challenges. The Board will be invited to consider the draft road map and<br \/>\nto provide further guidance.<br \/>\nCancer medicines<br \/>\nThe high prices of and growing expenditure on cancer medicines continue to impede progress towards<br \/>\nsustainable cancer care globally. Pursuant to resolution WHA70.12 (2017), the report by the Director-General<br \/>\nwill present a comprehensive technical report on pricing approaches, and their impact on availability and<br \/>\naffordability of medicines for the prevention and treatment of cancer, including options that might enhance the<br \/>\naffordability and accessibility of the medicines concerned.<br \/>\n.8 Follow-up to the high-level meetings of the nited Nations General Assembly on<br \/>\nhealth-related issues<br \/>\nAntimicrobial resistance<br \/>\nAntimicrobial resistance is a growing global challenge that impacts the achievement of the Sustainable<br \/>\nDevelopment Goals. The Political Declaration of the high-level meeting of the nited Nations General<br \/>\nAssembly on antimicrobial resistance reaffirmed that the blueprint for tackling antimicrobial resistance is<br \/>\nWHO\u2019s global action plan on antimicrobial resistance, and recognized that the overarching framework for<br \/>\naddressing antimicrobial resistance is provided by the One Health approach. At the request of ember States,<br \/>\nEB144\/1 (annotated)<br \/>\n4<br \/>\nthe Director-General will present a report to provide an update on the progress made in implementing the global<br \/>\naction plan highlighting the multisectoral collaboration between WHO, FAO and OIE and describing the<br \/>\nchallenges faced. The Board will be invited to note the report and provide further guidance.<br \/>\nPrevention and control of noncommunicable diseases<br \/>\nPursuant to resolution WHA71.2 (2018), the Director-General will report on the outcomes of the third High-level<br \/>\neeting of the General Assembly on the Prevention and Control of Non-communicable Diseases (New ork,<br \/>\n27 September 2018) and the follow-up work that the Secretariat will undertake to support governments in<br \/>\nfulfilling the commitments they made at the first, second and third High-level eetings on Non-communicable<br \/>\nDiseases. The Board will be invited to note the report.<br \/>\nEnding tuberculosis<br \/>\nThe first nited Nations High-level eeting on the Fight to End TB was held in New ork on<br \/>\n2 September 2018. The Director-General will submit a report providing an overview of the meeting and its<br \/>\noutcomes, pursuant to resolution WHA71.3 (2018), in which the Health Assembly made requests to all<br \/>\nstakeholders, including the Director-General, to support preparations for the High-level eeting.<br \/>\n.9 Eleventh revision of the International Classification of Diseases<br \/>\nThe version of the eleventh revision of the International Statistical Classification of Diseases and Related Health<br \/>\nProblems (ICD-11), designed to prepare implementation, was released in June 2018. This version supports<br \/>\ncountry-level preparations to facilitate: (i) implementation so that the final version of ICD-11 can be updated<br \/>\nbased on practical experience and (ii) submission of the final version for consideration by the Health Assembly.<br \/>\nThe report by the Director-General will provide an update on the feedback received on the implementation<br \/>\nversion, and a summary of the overall process. The Board will be invited to consider a draft resolution.<br \/>\ner ec c m er<br \/>\n.1 Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and<br \/>\naccess to vaccines and other benefits<br \/>\nPursuant to decision WHA70(10) (2017) and decision WHA71(11) (2018), the Director-General will submit a<br \/>\nreport on measures taken to implement the requests contained therein. The report will also summarize the main<br \/>\nelements of the analysis that the Director-General was requested to conduct in decision WHA70(10).<br \/>\n.2 ember State mechanism on substandard and falsified medical products<br \/>\nThe sixth and seventh meetings of the ember State mechanism on substandard and falsified medical products<br \/>\nwere held in Geneva, Switzerland from 30 November to 1 December 2017, and on 29 and 30 November 2018<br \/>\nrespectively. pdates on the implementation of the agreed list of prioritized activities for the period 201 2017<br \/>\nwere discussed, and a new list of prioritized activities for the period 2018 2019 was agreed. The outcome<br \/>\ndocuments from both meetings will form the basis for reporting to the Executive Board.<br \/>\n.3 Human resources for health<br \/>\nPursuant to resolution WHA 3.1 (2010) and decision WHA 8(11) (201 ) the Director-General will submit a<br \/>\nreport presenting aggregate findings across WHO regions as derived from the third round of national reporting<br \/>\non implementation of the WHO Global Code of Practice on the International Recruitment of Health Personnel.<br \/>\nThe Director-General will also submit a report summarizing progress made in the implementation of the WHO<br \/>\nGlobal Strategy on Human Resources for Health: Workforce 2030, in line with the request made by the Health<br \/>\nAssembly in resolution WHA 9.19 (201 ). The report will also provide details of progress made in respect of<br \/>\nEB144\/1 (annotated)<br \/>\n5<br \/>\nthe following resolutions: WHA 4. (2011) on health workforce strengthening WHA 4.7 (2011) on<br \/>\nstrengthening nursing and midwifery and WHA70. (2017) on human resources for health and implementation<br \/>\nof the outcomes of the nited Nations\u2019 High-Level Commission on Health Employment and Economic Growth.<br \/>\n.4 Promoting the health of refugees and migrants<br \/>\nPursuant to decision EB140(9) (2017) and resolution WHA70.1 (2017), the Director-General will submit a<br \/>\nreport providing an update on the status of the global action plan on the health of refugees and migrants.<br \/>\n. Accelerating cervical cancer elimination<br \/>\nVaccination against human papillomavirus infection, screening and treatment of pre-cancerous lesions, early<br \/>\ndetection and prompt treatment of early invasive cancers, and palliative care are proven and cost-effective<br \/>\nstrategies to address cervical cancer that, when implemented to scale and with adequate coverage, offer the<br \/>\nopportunity to eliminate cervical cancer as a public health problem, thus contributing to achievement of the<br \/>\nSustainable Development Goals, universal health coverage and other public health goals requiring multisectoral<br \/>\naction. The Board will be invited to note the report and provide further guidance.<br \/>\n. Patient safety<br \/>\nGlobal action on patient safety<br \/>\nPatient safety is a critical global public health ob ective. An inadmissible number of patients are harmed or die<br \/>\neach year as a result of unsafe care, placing a significant burden on health systems across the world and<br \/>\neopardizing progress towards universal health coverage. At the request of ember States, the Director-General<br \/>\nwill provide a report outlining the burden of patient harm, global efforts made to date in support of patient safety<br \/>\nand key global action areas and strategies for taking this work forward. The Executive Board will be invited to<br \/>\nnote the report and provide further guidance to advance global action on patient safety.<br \/>\nWater, sanitation and hygiene in health care facilities<br \/>\nThe first-ever global assessment on this matter, conducted in 201 by WHO and NICEF, found that nearly<br \/>\n40 of facilities lack water, 20 are without sanitation, and 3 do not have any hand hygiene materials. This<br \/>\nsituation undermines universal health coverage, quality care initiatives, and infection prevention and control<br \/>\nefforts. It also contributes to the spread of antimicrobial resistance. In response, launching the International<br \/>\nDecade for Action \u201cWater for Sustainable Development\u201d 2018 2028, the nited Nations Secretary-General<br \/>\nissued \u201ca global call to action on water, sanitation and hygiene\u201d in all health care facilities in arch 2018. In<br \/>\nlight of this background, and at the request of a ember State, the Director-General will submit a report on the<br \/>\nsub ect. The Board will be invited to note this report and provide guidance on future action.<br \/>\ner m r e er ce m er<br \/>\n7.1 WHO reform processes, including the transformation agenda, and implementation of<br \/>\nnited Nations development system reform<br \/>\nThe Executive Board will be invited to consider a series of reports on WHO reform processes. At the request of<br \/>\nember States, the Director-General will provide an overview of the work to date on WHO Transformation,<br \/>\nincluding information on the alignment of the transformation agenda with the reform of the nited Nations<br \/>\ndevelopment system, implications for WHO\u2019s presence in countries and the planned direction and priorities for<br \/>\n2019. The Director-General will also submit reports on: the evaluation of the Officers of the Board of their<br \/>\nexperience in using the proposed amended prioritization tool in respect of proposals for additional agenda items<br \/>\nthe proposed replacement or supplementation of gender-specific language in the Rules of Procedure of the<br \/>\ngoverning bodies and the changes to the texts that would be required. Following informal consultations on<br \/>\nEB144\/1 (annotated)<br \/>\n6<br \/>\ngovernance reform (Geneva, 12 and 13 September, and 23 and 24 October 2018) the Director-General will also<br \/>\ntransmit the Chairperson\u2019s summary and proposed way forward.<br \/>\n7.2 Evaluation of the election of the Director-General of the World Health Organization<br \/>\nFurther to the Board\u2019s request in decision EB142(8) (2018), the Secretariat will present proposals for<br \/>\nad ustments to the election process for the Director-General. Specifically, proposals relate to the Code of<br \/>\nConduct for the Election of the Director-General, the candidates\u2019 forum, the nomination of candidates by the<br \/>\nBoard, the voting process and the role of the Secretariat, as well as the overall duration and organization of the<br \/>\nelection process.<br \/>\n7.3 Engagement with non-State actors<br \/>\nIn line with resolution WHA 9.10 (201 ) and subparagraphs 8(a)(i) and 8(b) of the overarching framework of<br \/>\nthe Framework of Engagement with Non-State Actors, the Executive Board will consider the annual report on<br \/>\nengagement with non-State actors. The Board will be invited to consider a draft decision. In addition, paragraphs<br \/>\n0, 1 and 4 of the overarching framework mandate the Board, through its Programme Budget and<br \/>\nAdministration Committee, to consider applications for admittance of non-State actors into official relations and<br \/>\nto review collaboration with one third of the non-State actors in official relations in order to decide whether to<br \/>\nmaintain their official relations.<br \/>\n7.4 embership of the Independent Expert Oversight Advisory Committee if any<br \/>\n7. ultilingualism<br \/>\nPursuant to resolution WHA71.1 (2018) the Director-General will report on efforts to ensure availability of the<br \/>\nessential technical information of the Organization in written, audiovisual or digital form in the six official<br \/>\nlanguages. The Board will be invited to note this report and to provide guidance on next steps.<br \/>\n7. World health days<br \/>\nIn response to a request from the Officers of the Board, the Director-General will submit a report on the sub ect<br \/>\nof \u201cWorld Health Days.\u201d The document will provide a list of existing \u201cDays\u201d, \u201cWeeks\u201d and \u201c ears\u201d will give<br \/>\ndetails of the mandate and process for establishing and implementing such events and will describe possible<br \/>\napproaches for monitoring their usefulness. The Board will be invited to note the report and provide guidance.<br \/>\n7.7 Reports of committees of the Executive Board<br \/>\nFoundations and awards<br \/>\nIn addition to any other matters that may be awaiting its attention, the Board will consider the reports of the<br \/>\nselection panels for the following prizes to be awarded in 2019:<br \/>\nThe Sasakawa Health Prize, the nited Arab Emirates Health Foundation Prize, the State of uwait Health<br \/>\nPromotion Foundation Prize (the His Highness Sheikh Sabah Al-Ahmad Al-Jaber Al-Sabah Prize for Research<br \/>\nin Health Care for the Elderly and in Health Promotion), and the Dr Lee Jong-wook emorial Prize for Public<br \/>\nHealth. The Board will also be invited to approve the report of the Dr A.T. Shousha Foundation Committee and,<br \/>\nshould this prove necessary, to consider a report from the meeting of the Jacques Parisot Foundation.<br \/>\nEB144\/1 (annotated)<br \/>\n7<br \/>\n7.8 Future meetings of the governing bodies<br \/>\nProvisional agenda of the Seventy-second World Health Assembly<br \/>\nDate and place of the 14 th session of the Executive Board<br \/>\n8 c m er<br \/>\n8.1 Overview of financing and implementation of the Programme budget 2018 2019<br \/>\nThe Secretariat will present a report on the financing and implementation of the Programme budget 2018 2019.<br \/>\n8.2 Scale of assessments for 2020 2021<br \/>\nThe Board will be invited to consider the scale of assessments for 2020 2021, together with a draft resolution<br \/>\nrecommending adoption of the scale by the Seventy-second World Health Assembly.<br \/>\n8.3 Amendments to the Financial Regulations and Financial Rules if any<br \/>\nm re rce<br \/>\n9.1 Appointment of the Regional Director for South-East Asia<br \/>\nThe Regional Committee\u2019s proposal to the Board for the appointment of the Regional Director will be<br \/>\ntransmitted to the Board for its consideration.<br \/>\n9.2 Appointment of the Regional Director for the Western Pacific<br \/>\nThe Regional Committee\u2019s proposal to the Board for the appointment of the Regional Director will be<br \/>\ntransmitted to the Board for its consideration.<br \/>\n9.3 Statement by the representative of the WHO staff associations<br \/>\n9.4 Report of the Ombudsman<br \/>\n9. Human resources update, including on the global internship programme<br \/>\nThe report by the Secretariat will provide an update on the implementation of the Organization-wide human<br \/>\nresources strategy. Among other things, it will provide information on the following: mobility, implementation<br \/>\nof mandatory age of separation at , and prevention of sexual harassment. Lastly, pursuant to resolution<br \/>\nWHA71.13 (2018) on reform of the global internship programme, the Secretariat will provide an Annex,<br \/>\ndescribing the measures that have been put in place to operationalize the ob ectives of the resolution and giving<br \/>\ndetails of the mechanism by which financial and in-kind support will be provided to accepted interns.<br \/>\n9. Report of the International Civil Service Commission<br \/>\nThe Director-General will submit a report to the Board for its consideration containing details of the<br \/>\nrecommendations of the International Civil Service Commission to the nited Nations General Assembly.<br \/>\nEB144\/1 (annotated)<br \/>\n8<br \/>\n9.7 Amendments to the Staff Regulations and Staff Rules<br \/>\nAmendments to the Staff Rules made by the Director-General will be submitted for confirmation by the Board in<br \/>\naccordance with Staff Regulation 12.2. Proposed amendments to the Staff Regulations will be presented for<br \/>\nconsideration by the Board for submission to the Seventy-second World Health Assembly.<br \/>\n10 er r rm<br \/>\n10.1 Outcome of the Second International Conference on Nutrition<br \/>\nThe Director-General will present a report illustrating the 2017 2018 policy development at national and global<br \/>\nlevel following the Second International Conference on Nutrition and the proclamation of the nited Nations<br \/>\nDecade of Action on Nutrition. The report will also provide an update on the implementation of the<br \/>\nrecommendations of the Ending Childhood Obesity Commission. The report will also set out a number of areas<br \/>\nwhere intensified action is required.<br \/>\n10.2 Evaluation: update<br \/>\nThe Board will be invited to consider a report that: (a) provides a brief progress update in respect of ongoing<br \/>\nwork and, specifically, an update on measures to take forward the organizational learning component of<br \/>\nevaluation and (b) outlines the scope of and framework for the review of 40 years of primary health care to be<br \/>\ncarried out in 2019. The Board will be invited to note the report and consider the proposal for the review of 40<br \/>\nyears of implementation of primary health care at country level.<br \/>\n10.3 Reports of advisory bodies<br \/>\nExpert committees and study groups<br \/>\nIn compliance with Regulation 4.23 of the Regulations for Expert Advisory Panels and Committees, the<br \/>\nDirector-General will submit to the Board for its consideration a report on meetings of expert committees and<br \/>\nstudy groups, including a summary of the recommendations contained in the reports of expert committees and<br \/>\nobservations on their significance for public health policies and implications for the Organization\u2019s programmes.<br \/>\nIn a second report, the Secretariat will provide details of both meetings and membership of expert committees<br \/>\nthat met in 2018.<br \/>\n11 re e e<br \/>\nNote:<br \/>\n1. At their consultation with the Director-General on 5 October 2018, convened in accordance with Rule 8<br \/>\nof the Rules of Procedure of the Executive Board, the Officers of the Executive Board agreed to recommend the<br \/>\nfollowing in respect of the draft provisional agenda that had been transmitted to Member States for comment on<br \/>\n26 June 2018:<br \/>\nto move \u2013 in line with the proposal made by the Governments of Uruguay and Switzerland \u2013 existing<br \/>\nitem 10.1 on Outcome of the third High-level meeting of the General Assembly on the Prevention and<br \/>\ncontrol of Non-communicable diseases in order to place it under the section on \u201cStrategic priority<br \/>\nmatters\u201d. At the same time, the Officers decided to combine that item, under new item 5.8, with two<br \/>\nfurther reports on high-level meetings of the United Nations General Assembly. This implied moving<br \/>\nexisting item 10.3 on Outcome of the high-level meeting of the General Assembly on ending<br \/>\ntuberculosis and accepting for addition to the provisional agenda of the 144th session of the<br \/>\nExecutive Board the item on antimicrobial resistance, proposed by the Governments of Canada, the<br \/>\nEB144\/1 (annotated)<br \/>\n9<br \/>\nUnited Kingdom of Great Britain and Northern Ireland and the United States of America. The new item<br \/>\nwould be entitled \u201cFollow-up to the high-level meetings of the United Nations General Assembly on<br \/>\nhealth-related issues\u201d and would have three bullet points: Prevention and control of<br \/>\nnoncommunicable diseases, Ending tuberculosis and Antimicrobial resistance.<br \/>\nto accept for addition to the provisional agenda of the 144th session of the Executive Board, under a<br \/>\nnew item 5.5, entitled \u201cUniversal health coverage\u201d, the following proposed items, which would be<br \/>\npresented by means of three bullet points:<br \/>\n\u201cCommunity health workers delivering primary health care: opportunities and challenges\u201d<br \/>\n(proposed by the Government of Ethiopia)<br \/>\n\u201cPrimary health care towards universal health coverage\u201d (proposed by the Government of<br \/>\nKazakhstan)<br \/>\n\u201cPreparation for the high-level meeting of the United Nations General Assembly on universal<br \/>\nhealth coverage\u201d (proposed by the Governments of Japan and Thailand1<br \/>\n)<br \/>\nto defer to a future session of the Executive Board, consideration of the item on \u201cFurther actions to<br \/>\naddress the global burden of epilepsy and its health and social implications at the country level\u201d<br \/>\nproposed by the Governments of Croatia and Honduras. There was agreement that the subject had<br \/>\nrecently been discussed in the governing bodies. The Secretariat was asked to advise on the placement<br \/>\nof the item on the forward-looking planning schedule of expected agenda items.<br \/>\nto defer to a future session of the Executive Board, consideration of the item on \u201cFollow-up on the<br \/>\nimplementation of paragraph 3 of decision WHA70(18) on the public health dimension of the world<br \/>\ndrug problem\u201d, which had been proposed by the Governments of Guatemala, Mexico, Paraguay and<br \/>\nPortugal. That subject also had recently been discussed in the governing bodies. The Secretariat was<br \/>\nasked to advise on the placement of the item on the forward-looking planning schedule of expected<br \/>\nagenda items. In view of the importance of the matter, it was also agreed that the Secretariat would<br \/>\nprovide a briefing session for Member States on activities developed by WHO, as well as submitting a<br \/>\nreport on the issue for the consideration of the Health Assembly.<br \/>\nto accept for addition to the provisional agenda of the 144th session of the Executive Board, the item<br \/>\non \u201cAccelerating cervical cancer elimination,\u201d which had been proposed by the Governments of<br \/>\nAustralia, Brazil, Thailand and Zambia. There was agreement that including a separate item on<br \/>\ncervical cancer elimination would allow for a broader discussion than if the matter were included<br \/>\nunder the item on access to medicines and vaccines. That way, consideration could be given to all the<br \/>\ndimensions of the approach needed to the subject.<br \/>\nto accept for addition on the provisional agenda of the 144th session of the Board the proposed new<br \/>\nitems entitled \u201cGlobal action on patient safety\u201d (proposed by the Governments of thirty-four Member<br \/>\nStates) and \u201cWater, sanitation and hygiene in health care facilities\u201d (proposed by the Government of<br \/>\nthe United Republic of Tanzania). The two subjects would be considered as bullet points under a new<br \/>\nitem 6.6, entitled \u201cPatient safety\u201d.<br \/>\nto defer to the 145th session of the Executive Board, consideration of the item on \u201cStandardization of<br \/>\nmedical devices nomenclature\u201d proposed by the Government of Brazil. Although the Officers<br \/>\nrecognized the importance of the subject, there was agreement that there would be insufficient time at<br \/>\nthe Board\u2019s 144th session to give the matter the consideration that it merited. Deferral would also give<br \/>\nthe Secretariat additional time to prepare a comprehensive report, including through consultations.<br \/>\n1 On behalf of the ember States of the South-East Asia Region.<br \/>\nEB144\/1 (annotated)<br \/>\n10<br \/>\nto amend \u2013 in line with the proposal made by the Government of France, with support from the<br \/>\nGovernments of Belgium, Czech Republic, Germany, Latvia and Switzerland \u2013 the title of the existing<br \/>\nitem on WHO reform, changing it to read \u201cWHO reform processes, including the transformation<br \/>\nagenda, and implementation of United Nations Development System reform.\u201d<br \/>\nto amend \u2013 in line with the proposal made by the Secretariat \u2013 the title of the existing item 5.6 on<br \/>\nAddressing the global shortage of, and access to, medicines and vaccines, including for cancer<br \/>\nprevention and control, changing it to read as follows:<br \/>\nMedicines, vaccines and health products<br \/>\nAccess to medicines and vaccines<br \/>\nCancer medicines<br \/>\n2. Following a discussion launched by the Chairperson, the Officers of the Executive Board also asked that<br \/>\nthe Secretariat\u2019s human resources update to the Board in January 2019 include information that would enable<br \/>\nthe Board to consider, in a transparent and well-informed manner, the issue of a housing allowance for the<br \/>\nDirector-General. The matter had not been discussed by the governing bodies for a long time; consideration<br \/>\nshould also be given to the practice in other United Nations specialized agencies.<br \/>\nStructure of the Provisional agenda of the Executive Board at its 144th session<br \/>\n3. The Chairperson recalled that during the continuing consultations on Governance Reform, one Member<br \/>\nState had called for an explanation of the decision, taken by the Officers at their meeting on 31 July and<br \/>\n1 August 2017, to change the structure of the agenda based on the actions and outcomes expected from the<br \/>\nBoard. As a result, strategic issues of high priority had been grouped together separately. In the view of the<br \/>\nMember State concerned, the decision had not been taken with the proper consideration of the Executive Board.<br \/>\nThe Officers agreed to recommend that the Executive Board at its 144th session in January 2019, take<br \/>\nadvantage of its first item (adoption of the agenda) to consider and approve the current structure of its agenda.<br \/>\nPreparation of the Provisional agenda of the Executive Board at its 144th session<br \/>\n4. The Chairperson reminded the Secretariat of the list of proposals on governance reform approved by the<br \/>\nBoard at its 143rd session and requested it to provide a new Provisional agenda on the basis of the Officers\u2019<br \/>\ndiscussions, together with additional information on: how each item would be handled; what action was<br \/>\nexpected of the Board; and how much time would be available for members and non-members of the Board to<br \/>\nexpress their governments\u2019 position. The Officers also stressed the importance in the future of organizing the<br \/>\nagenda in line with the General Programme of Work rather than according strategic priority to certain items, as<br \/>\nthat gave the impression that other items were less important.<\/p>\n"},"caption":{"rendered":"<p>Invitation_EB144 NSA English 20, AVENUE APPIA \u2013 CH-1211 GENEVA 27 \u2013 SWITZERLAND \u2013 TEL CENTRAL +41 22 791 2111 \u2013 FAX CENTRAL +41 22 791 3111 \u2013 WWW.WHO.INT &#8230; ENCLS: (3) EB\/19.4 The Director-General of the World Health Organization (WHO) has the honour to invite the non-State actors in official relations with WHO, in accordance [&hellip;]<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":25069,"source_url":"https:\/\/www.wma.net\/wp-content\/uploads\/2018\/12\/Invitation_EB144-NSA-English.pdf","_links":{"self":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media\/12167"}],"collection":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/comments?post=12167"}]}}